Dehydroepiandrosterone Supplementation May Benefit Women with Asthma Who Have Low Androgen Levels: A Pilot Study

INTRODUCTION: Among individuals with severe asthma, FEV(1) is low in individuals with low dehydroepiandrosterone (DHEA) sulfate (DHEAS) levels. In the Severe Asthma Research Program (SARP), no women with DHEAS > 200 μg/dL had an FEV(1) < 60% predicted. DHEA has benefited patients with COPD and...

Descripción completa

Detalles Bibliográficos
Autores principales: Marozkina, Nadzeya, Zein, Joe, DeBoer, Mark D., Logan, Laurie, Veri, Laura, Ross, Kristie, Gaston, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967310/
https://www.ncbi.nlm.nih.gov/pubmed/32026412
http://dx.doi.org/10.1007/s41030-019-00101-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967310/
https://www.ncbi.nlm.nih.gov/pubmed/32026412
http://dx.doi.org/10.1007/s41030-019-00101-9

Ejemplares similares